393
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Artificial intelligence model with deep learning in nonalcoholic fatty liver disease diagnosis: genetic based artificial neural networks

ORCID Icon & ORCID Icon
Pages 398-406 | Received 26 Aug 2022, Accepted 17 Nov 2022, Published online: 30 Nov 2022

References

  • Baffy, G.; Bosch, J. Overlooked Subclinical Portal Hypertension in Non-Cirrhotic NAFLD: Is it Real and How to Measure it? J. Hepatol. 2022, 76, 458–463. DOI: 10.1016/j.jhep.2021.09.029.
  • Aggarwal, P.; Alkhouri, N. Artificial İntelligence in Nonalcoholic Fatty Liver Disease: A New Frontier in Diagnosis and Treatment. Clin.Liver Dis. (Hoboken) 2021, 17, 392–397. DOI: 10.1002/cld.1071.
  • Marchesini, G.; Marzocchi, R.; Agostini, F.; Bugianesi, E. Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome. Curr. Opin. Lipidol. 2005, 16, 421–427. DOI: 10.1097/01.mol.0000174153.53683.f2.
  • Mahana, D.; Trent, C. M.; Kurtz, Z. D.; Bokulich, N. A.; Battaglia, T.; Chung, J.; Müller, C. L.; Li, H.; Bonneau, R. A.; Blaser, M. J. Antibiotic Perturbation of the Murine Gut Microbiome Enhances the Adiposity, İnsulin Resistance, and Liver Disease Associated with High-Fat Diet. Genome Med. 2016, 8, 1–20. DOI: 10.1186/s13073-016-0297-9.
  • Procino, F.; Misciagna, G.; Veronese, N.; Caruso, M. G.; Chiloiro, M.; Cisternino, A. M.; Notarnicola, M.; Bonfiglio, C.; Bruno, I.; Buongiorno, C.; MICOL GROUP.; et al. Reducing NAFLD‐Screening Time: A Comparative Study of Eight Diagnostic Methods Offering an Alternative to Ultrasound Scans. Liver Int. 2019, 39, 187–196. DOI: 10.1111/liv.13970.
  • Ahn, J. C.; Connell, A.; Simonetto, D. A.; Hughes, C.; Shah, V. H. Application of Artificial İntelligence for the Diagnosis and Treatment of Liver Diseases. Hepatology 2021, 73, 2546–2563. DOI: 10.1002/hep.31603.
  • Sorino, P.; Campanella, A.; Bonfiglio, C.; Mirizzi, A.; Franco, I.; Bianco, A.; Caruso, M. G.; Misciagna, G.; Aballay, L. R.; Buongiorno, C.; et al. Development and Validation of a Neural Network for NAFLD Diagnosis. Sci. Rep. 2021, 11, 1–13. DOI: 10.1038/s41598-021-99400-y.
  • Mai, R.-Y.; Zeng, J.; Mo, Y.-S.; Liang, R.; Lin, Y.; Wu, S.-S.; Piao, X.-M.; Gao, X.; Wu, G.-B.; Li, L.-Q.; Ye, J.-Z. Artificial Neural Network Model for Liver Cirrhosis Diagnosis in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma. Ther. Clin. Risk Manag. 2020, 16, 639–649. DOI: 10.2147/TCRM.S257218.
  • Fialoke, S.; Malarstig, A.; Miller, M. R.; Dumitriu, A. Application of Machine Learning Methods to Predict Non-Alcoholic Steatohepatitis (NASH) in Non-Alcoholic Fatty Liver (NAFL) Patients. AMIA Annu. Symp. Proc. 2018, 2018, 430–439.
  • Okanoue, T.; Shima, T.; Mitsumoto, Y.; Umemura, A.; Yamaguchi, K.; Itoh, Y.; Yoneda, M.; Nakajima, A.; Mizukoshi, E.; Kaneko, S.; Harada, K. Artificial İntelligence/Neural Network System for the Screening of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Hepatol. Res. 2021, 51, 554–569. DOI: 10.1111/hepr.13628.
  • Chen, Y.-S.; Chen, D.; Shen, C.; Chen, M.; Jin, C.-H.; Xu, C.-F.; Yu, C.-H.; Li, Y.-M. A Novel Model for predicting fatty liver Disease by Means of an Artificial Neural Network. Gastroenterol. Rep. (Oxf) 2021, 9, 31–37. DOI: 10.1093/gastro/goaa035.
  • Machado, M. V.; Cortez-Pinto, H. Non-İnvasive Diagnosis of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal. J. Hepatol. 2013, 58, 1007–1019. DOI: 10.1016/j.jhep.2012.11.021.
  • Nam, D.; Chapiro, J.; Paradis, V.; Seraphin, T. P.; Kather, J. N. Artificial İntelligence in Liver Diseases: improving Diagnostics, Prognostics and Response Prediction. JHEP Rep. 2022, 4, 100443. DOI: 10.1016/j.jhepr.2022.100443.
  • Cao, W.; An, X.; Cong, L.; Lyu, C.; Zhou, Q.; Guo, R. Application of Deep Learning in Quantitative Analysis of 2‐Dimensional Ultrasound İmaging of Nonalcoholic Fatty Liver Disease. J. Ultrasound Med. 2020, 39, 51–59. DOI: 10.1002/jum.15070.
  • Heinemann, F.; Birk, G.; Stierstorfer, B. Deep Learning Enables Pathologist-like Scoring of NASH Models. Sci. Rep. 2019, 9, 1–10. DOI: 10.1038/s41598-019-54904-6.
  • Chou, T.-H.; Yeh, H.-J.; Chang, C.-C.; Tang, J.-H.; Kao, W.-Y.; Su, I.-C.; Li, C.-H.; Chang, W.-H.; Huang, C.-K.; Sufriyana, H.; Su, E. C.-Y. Deep Learning for Abdominal Ultrasound: A Computer-Aided Diagnostic System for the Severity of Fatty Liver. J. Chin. Med. Assoc. 2021, 84, 842–850. DOI: 10.1097/JCMA.0000000000000585.
  • Byra, M.; Styczynski, G.; Szmigielski, C.; Kalinowski, P.; Michałowski, Ł.; Paluszkiewicz, R.; Ziarkiewicz-Wróblewska, B.; Zieniewicz, K.; Sobieraj, P.; Nowicki, A. Transfer Learning with Deep Convolutional Neural Network for Liver Steatosis Assessment in Ultrasound İmages. Int. J. Comput. Assist. Radiol. Surg. 2018, 13, 1895–1903. DOI: 10.1007/s11548-018-1843-2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.